tyrosine has been researched along with cicaprost in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berg, M; Offermanns, S; Schultz, G; Seifert, R | 1 |
Lo, RK; Wise, H; Wong, YH | 1 |
2 other study(ies) available for tyrosine and cicaprost
Article | Year |
---|---|
Synthetic lipopeptide Pam3CysSer(Lys)4 is an effective activator of human platelets.
Topics: Blood Platelets; Calcium; Dose-Response Relationship, Drug; Epoprostenol; Genistein; Humans; Intracellular Membranes; Isoflavones; Lipoproteins; Osmolar Concentration; Phosphorylation; Platelet Activation; Platelet Aggregation; Protein-Tyrosine Kinases; Receptors, Epoprostenol; Receptors, Prostaglandin; Serotonin; Tyrosine | 1994 |
Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK.
Topics: Cell Line, Tumor; Dose-Response Relationship, Drug; Epoprostenol; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Proteins; Humans; Leukemia, Erythroblastic, Acute; MAP Kinase Kinase 1; MAP Kinase Kinase 4; MAP Kinase Kinase Kinases; Pertussis Toxin; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Receptors, Epoprostenol; Serine; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Time Factors; Transcription, Genetic; Tyrosine | 2006 |